Clinical Trial Update: Adjunctive NAC in Adult Patients With Pulmonary Tuberculosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating adjunctive N-acetylcysteine in adults with pulmonary tuberculosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: The Aurum Institute NPC | Conditions: Tuberculosis, Pulmonary | Phase 2 | Status: COMPLETED